C-erbb-2 external domain:gp75

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 19/00 (2006.01) A61K 39/395 (2006.01) C07K 14/71 (2006.01) C07K 16/32 (2006.01) C07K 16/42 (2006.01) C12N 15/12 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) C12N 15/62 (2006.01)

Patent

CA 2042064

Disclosed are methods and compositions for identifying malignant tumors that overexpress the c-erbB-2 oncogene. Assays useful for diagnosis and prognosis of neoplastic disease are provided which detect the external domain of c-erbB-2, the glycoprotein gp75 and quantitate the level of gp75 in the biological fluids of mammals carrying a tumor burden. Further disclosed are recombinant, synthetically and otherwise biologically produced novel proteins and polypeptides which are encoded by the external domain DNA sequence of the c-erbB-2 oncogene (the gp75 gene) or fragments thereof. Such gp75 proteins and polypeptides are useful as vaccines, therapeutically in the treatment of cancer either alone or in combination with chemotherapeutic agents. Also disclosed are antibodies to such gp75 proteins and polypeptides which are useful diagnostically and therapeutically. Still further disclosed are test kits embodying the assays of this invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

C-erbb-2 external domain:gp75 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C-erbb-2 external domain:gp75, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-erbb-2 external domain:gp75 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1819334

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.